Investing

Ascendis Pharma : ASND

ASND

Stock Data

$254.83

$4.98 (1.99%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Ascendis Pharma A/S is a biopharmaceutical firm based in Hellerup, Denmark, founded in 2006. It specializes in creating innovative treatments for unmet medical needs, with a notable product, SKYTROFA, designed for individuals with growth hormone deficiency (GHD). Beyond SKYTROFA, Ascendis is actively working on a robust pipeline focused on rare endocrinology diseases and exploring new therapies in oncology.

All Ascendis Pharma Articles

1 Article

Danielle Liverance | Jul 9, 2026 at 1:29 PM EDT

Why Crinetics Stock Soared 99% This Week

Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this week, from $42.03 at Monday’s close, to…